Kwangdong Pharmaceutical Co Ltd
KRX:009290

Watchlist Manager
Kwangdong Pharmaceutical Co Ltd Logo
Kwangdong Pharmaceutical Co Ltd
KRX:009290
Watchlist
Price: 6 040 KRW -0.17% Market Closed
Market Cap: 242.1B KRW

Intrinsic Value

The intrinsic value of one Kwangdong Pharmaceutical Co Ltd stock under the Base Case scenario is 23 620.75 KRW. Compared to the current market price of 6 040 KRW, Kwangdong Pharmaceutical Co Ltd is Undervalued by 74%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

Intrinsic Value
23 620.75 KRW
Undervaluation 74%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
Kwangdong Pharmaceutical Co Ltd

What is Valuation History?
Ask AI Assistant
What other research platforms think about Kwangdong Pharmaceutical Co Ltd?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is Kwangdong Pharmaceutical Co Ltd valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Kwangdong Pharmaceutical Co Ltd.

Explain Valuation
Compare Kwangdong Pharmaceutical Co Ltd to

Fundamental Analysis

Kwangdong Pharmaceutical Co Ltd
KRX:009290
KR
Pharmaceuticals
Market Cap
237.6B KRW
IPO
Nov 17, 1989
KR
Pharmaceuticals
Market Cap
237.6B KRW
IPO
Nov 17, 1989
Price
â‚©
â‚©
Company Overview
Loading...
Economic Moat
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about Kwangdong Pharmaceutical Co Ltd?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Kwangdong Pharmaceutical Co Ltd

Current Assets 719.1B
Cash & Short-Term Investments 165.5B
Receivables 276.1B
Other Current Assets 277.6B
Non-Current Assets 451.2B
Long-Term Investments 142B
PP&E 249B
Intangibles 37.6B
Other Non-Current Assets 22.5B
Current Liabilities 461.3B
Accounts Payable 169.8B
Accrued Liabilities 1.9B
Short-Term Debt 208.9B
Other Current Liabilities 80.7B
Non-Current Liabilities 129.9B
Long-Term Debt 71.4B
Other Non-Current Liabilities 58.5B
Efficiency

Free Cash Flow Analysis
Kwangdong Pharmaceutical Co Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Kwangdong Pharmaceutical Co Ltd

Revenue
1.6T KRW
Cost of Revenue
-1.3T KRW
Gross Profit
283.7B KRW
Operating Expenses
-267.9B KRW
Operating Income
15.9B KRW
Other Expenses
11.3B KRW
Net Income
27.2B KRW
Fundamental Scores

Profitability Score
Profitability Due Diligence

Kwangdong Pharmaceutical Co Ltd's profitability score is 43/100. The higher the profitability score, the more profitable the company is.

Healthy Gross Margin
Sustainable 3Y Average Gross Margin
ROE is Increasing
Net Margin is Increasing
43/100
Profitability
Score

Kwangdong Pharmaceutical Co Ltd's profitability score is 43/100. The higher the profitability score, the more profitable the company is.

Solvency Score
Solvency Due Diligence

Kwangdong Pharmaceutical Co Ltd's solvency score is 47/100. The higher the solvency score, the more solvent the company is.

Low D/E
Long-Term Solvency
Short-Term Solvency
Average Altman Z-Score
47/100
Solvency
Score

Kwangdong Pharmaceutical Co Ltd's solvency score is 47/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

Price Targets Summary
Kwangdong Pharmaceutical Co Ltd

There are no price targets for Kwangdong Pharmaceutical Co Ltd.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for Kwangdong Pharmaceutical Co Ltd is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y
What is the Intrinsic Value of one Kwangdong Pharmaceutical Co Ltd stock?

The intrinsic value of one Kwangdong Pharmaceutical Co Ltd stock under the Base Case scenario is 23 620.75 KRW.

Is Kwangdong Pharmaceutical Co Ltd stock undervalued or overvalued?

Compared to the current market price of 6 040 KRW, Kwangdong Pharmaceutical Co Ltd is Undervalued by 74%.

Back to Top